Literature DB >> 2787852

Immunoblot reactivity of a non-HIV protein with human sera. Transfusion Safety Study Group.

G L Norman1, S S Barker, S Rasheed.   

Abstract

Examination of serum for the presence of antibodies to the human immunodeficiency virus (HIV) by immunoblot analysis requires precise identification of reactivities with various HIV specific proteins. During a recent survey of approximately 2,000 sera, we identified 22 sera from non-HIV-reactive blood donors and 2 from individuals receiving blood products for congenital blood disorders, which consistently and exclusively reacted with a protein of a molecular weight slightly greater than 65,000 daltons (termed AT65). Since the HIV pol p65 protein reacts with specific antibodies at about the same position (i.e., 65,000 daltons), it was essential to determine the viral or nonviral origin of the AT65 reactivity. Our data indicate that the AT65 reaction is due to a protein present on normal or activated lymphocytes, which can co-purify with HIV preparations used for immunoblot analysis. Recognition of HIV-specific p65 and nonspecific AT65 reactions is important to those responsible for interpretation of HIV immunoblots and may aid in the evaluation of some "indeterminant" results.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787852     DOI: 10.1002/jcla.1860030303

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  2 in total

1.  Antibodies to human immunodeficiency virus (HIV-1) in autoimmune diseases: primary Sjögren's syndrome, systemic lupus erythematosus, rheumatoid arthritis and autoimmune thyroid diseases.

Authors:  J Coll; J Palazon; H Yazbeck; J Gutierrez; C Aubo; P Benito; P Jagiello; H Maldyk; J Marrugat; J Anglada
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

2.  Anti-human immunodeficiency virus type 1 antibodies of noninfected subjects are not related to autoantibodies occurring in systemic diseases.

Authors:  R Kämmerer; P Bürgisser; P C Frei
Journal:  Clin Diagn Lab Immunol       Date:  1995-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.